Second primary lung cancer in Flanders: frequency, clinical presentation, treatment and prognosis

Patient and tumour characteristics of 23 patients presenting with a second primary lung cancer were analysed and compared with 534 patients with radically resected stage 1 non-small cell lung cancer (NSCLC). None of these characteristics is associated with a higher occurrence rate for second primary...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Lung cancer (Amsterdam, Netherlands) Netherlands), 1996-11, Vol.15 (3), p.281-295
Hauptverfasser: Van Meerbeeck, J., Weyler, J., Thibaut, A., Vansteenkiste, J., Aumann, J., Deneffe, G., Galdermans, D., Haelterman, M., Joos, G., Noppen, M., Pinson, P., Tasson, J., Van Den Eeckhout, A., Uydebrouck, M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Patient and tumour characteristics of 23 patients presenting with a second primary lung cancer were analysed and compared with 534 patients with radically resected stage 1 non-small cell lung cancer (NSCLC). None of these characteristics is associated with a higher occurrence rate for second primary lung cancer. Prognosis in the latter patients is significantly worse than after resection of a ‘solitary’ NSCLC: the median survival time (MST) after resection of the first tumour is 50 months; after diagnosis of the second tumour only 14 months. Surgically retreated patients have a prognosis that is similar to that after resection of a ‘solitary’ NSCLC. No separate independent prognostic factors responsible for this surivival difference could be isolated. Squamous histology and central location are associated with a longer recurrence free survival time. We conclude that the occurrence of a second primary lung cancer can not be predicted based on patient or tumour characteristics and that only surgical retreatment offers a chance of long survival in these patients.
ISSN:0169-5002
1872-8332
DOI:10.1016/0169-5002(95)00593-5